The largest database of trusted experimental protocols

66 protocols using live dead blue

1

Antibody-based Adipose Tissue Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies to IRβ, P-T308-Akt, P-S473-Akt and Pan-Akt (all used at 1/1000 dilution) were from Cell Signaling. UCP1 antibody (#10983) was from AbCam (used at 1/100 for IHC and at 1/1000 for western blot). Live/dead Blue (Molecular Probes, L23105), CD31-PE-CY7 (eBioscience, 25-0311)(used at 1/1000), CD45-PE-CY7 (eBioscience, 25-0451) (used at 1/1000), CD29-AlexaFluor700 (Biolegend, 102218)(used at 1/400), CD34-AlexaFluor647 (Biolegend, 119314)(used at 1/200), Sca1-Pacific Blue (BD Bioscience, 560653)(used at 1/1000), CD45-FITC (eBioscience, 11-0451) (used at 1/200) were used for flow cytometry. CL316,243 was from Tocris.
+ Open protocol
+ Expand
2

Antibody-based Adipose Tissue Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies to IRβ, P-T308-Akt, P-S473-Akt and Pan-Akt (all used at 1/1000 dilution) were from Cell Signaling. UCP1 antibody (#10983) was from AbCam (used at 1/100 for IHC and at 1/1000 for western blot). Live/dead Blue (Molecular Probes, L23105), CD31-PE-CY7 (eBioscience, 25-0311)(used at 1/1000), CD45-PE-CY7 (eBioscience, 25-0451) (used at 1/1000), CD29-AlexaFluor700 (Biolegend, 102218)(used at 1/400), CD34-AlexaFluor647 (Biolegend, 119314)(used at 1/200), Sca1-Pacific Blue (BD Bioscience, 560653)(used at 1/1000), CD45-FITC (eBioscience, 11-0451) (used at 1/200) were used for flow cytometry. CL316,243 was from Tocris.
+ Open protocol
+ Expand
3

Flow Cytometric Characterization of NPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved NPCs were rapidly thawed, washed with fluorescence‐activated cell sorting buffer (FACS) (phosphate‐buffered saline with 2% heat‐inactivated FBS), and quantified with viability staining using Moxicyte and Moxiflow cytometry (Orflo, Ketchum, IN). A total of 1.5 million NPCs were placed into three tubes and stained with the viability dye live dead blue (Molecular Probes, Eugene, OR). NPCs were then washed, stained with three surface antibody panels detailed in http://onlinelibrary.wiley.com/doi/10.1002/hep4.1160/full, fixed with 1% paraformaldehyde, and run on the LSRII flow cytometer (BD Biosciences, San Jose, CA). Data were acquired using BD FACSDIVA software (BD Biosciences). The gating strategies are described in http://onlinelibrary.wiley.com/doi/10.1002/hep4.1160/full. FACS data were analyzed using FlowJo, version 10.1 (Ashland, OR).
+ Open protocol
+ Expand
4

Phenotypic Characterization of Ascites Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ascites cells were thawed and approximately 100 µL cell pellet of each ascites was used for staining. Cells were re‐suspended in 100 µL of ‘supermix’ including LIVE/DEAD Blue (Molecular Probes™ L23105): 0.1 µL of probe/100 µL of FACS buffer (2% FBS + 0.1% sodium azide in Ca/Mg2+‐free PBS). Samples were then incubated in the dark, at 4°C for 20 min. After washing with FACS buffer cells were re‐suspended in 100 µL of antibody ‘mastermix’, pipetting and incubated in the dark, at 4°C for 30 min. The antibody ‘mastermix’ contained the panel of antibodies diluted 1:200 in FACS buffer as specified in Table S7. After incubation with antibodies, the samples were topped up with 1 mL of FACS buffer and spun at 300 × g, 5 min, 20°C. Cells were again re‐suspended in 200 µL of FACS buffer and the whole suspension was filtered through 70 µm cell‐strainer cap (352235, Falcon), vortexed and directly used for flow cytometry (FC) measurement using Cytek® Aurora spectral flow cytometer. Data processing and analysis was done in FlowJo™_v10.8.1. software and flowCore and CATALYST packages in R.
+ Open protocol
+ Expand
5

Spectral Flow Cytometry of Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
First, cells were stained with a live/dead marker by incubating 3 × 106 cells with 1:1000 v/v Live/dead blue (Life Technologies) in 100 µl PBS for 30 min at room temperature. The following washing and incubation steps were performed with fluorescence activated cell sorting (FACS) buffer (PBS [Life technologies] containing 1% FBS [Sigma-Aldrich], 0.09 % NaN3 [Sigma-Aldrich], and 2 mM EDTA [Merck]). Blocking of Fc receptors was done before staining by incubating cells at 4 °C for 20 min with CD16/CD32 mAb either purified or labeled with PerCp/Cy5.5 (progenitor panel). After centrifugation cells were stained with all extracellular antibodies simultaneously at 4 °C for 20 min. The antibodies used are listed in Supplemental Table S1. We used spectral flow cytometry, which allows the use of fluorochromes with similar excitation and emission maxima in a single panel by measuring the entire emission spectrum of a fluorochrome and then unmixing the spectrum to identify individual fluorochromes, to simultaneously detect 28 cellular proteins After washing, cells were fixed with FoxP3 Fix/Perm buffer set (BioLegend) and stored over night at 4 °C in the dark. Intracellular staining was performed in FoxP3 Fix/Perm buffer at room temperature for 30 min. Samples were acquired on an AURORA spectral flow cytometer (Cytek Biosciences) and analyzed using OMIQ software (OMIQ).
+ Open protocol
+ Expand
6

Isolation and Cytokine Profiling of Human Monocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
After written informed consent was provided, human donor blood was
obtained at the National Institutes of Health (NIH) Clinical Center under
Institutional Review Board (IRB)–approved protocols. PBMCs were purified
from blood by Ficoll (Fisher Scientific) density gradient centrifugation, washed
with RPMI 1640 plus penicillin, streptomycin, and L-glutamine (Gibco) along with
10% FBS (Sigma-Aldrich). Cells were resuspended to a concentration of 1
× 106 cells/ml and aliquoted (1 ml/well) into 48-well plates.
LPS (0.5 μg/ml Sigma-Aldrich) and brefeldin A (5 μg/ml,
Sigma-Aldrich) were added before incubation at 37 °C overnight. After
incubation, cells were washed with FACS buffer and stained with LIVE/DEAD Blue
(Life Technologies). Cells were then fixed in 1.6% paraformaldehyde for
10 min at room temperature, spun down, resuspended in 100% cold
methanol, and incubated overnight at −20 °C. Cells were then
washed and stained with fluorochrome-conjugated antibodies: CD14 (MφP9,
BD Biosciences), CD11c (B-ly6, BD Biosciences), Ikaros (R32-1149, BD
Biosciences), IL-1β (AS10, BD Biosciences), TNF-α (MAb11, BD
Biosciences), and IL-6 (MQ2-13A5, eBioscience). The data were gated on
CD11c+CD14+ monocytes.
+ Open protocol
+ Expand
7

Multiparameter Flow Cytometry for Myeloid Cell Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Single cell suspensions were stained with Fc receptor block (TruStain fcX, Biolegend) along with the appropriate anti-mouse antibodies: CD45 (AF700; clone 30-F11, Biolegend), TNFα (AF700; clone MP6-XT22, Biolegend), CD11b (BV605 or BV650; clone M1/70, Biolegend), Ly6C (BV711; clone HK1.4; Biolegend), Ly6G (APC-Cy7; clone 1A8), CD115 (APC; clone AFS98, Biolegend) or PE-Cy7; AFS98, eBioscience), CD68 (PE; clone FA-11, Biolegend). A lineage gate was used to exclude other cell populations and consisted of the following biotinylated antibodies: CD3 (clone 145-2C11, Biolegend), CD19 (clone 6D5, Biolegend), NK1.1 (clone PK136, Biolegend), Ter119 (clone TER-119, Biolegend), and SiglecF (PE-CF594; E50-2440, BD Biosciences). A fixable stain (LIVE/DEAD Blue, Life Technologies) was used to exclude dead cells. For intracellular staining, cells were first stained for surface markers, fixed in 2% PFA, then permeabilized in 0.5% Saponin (Sigma), and stained for intracellular markers. Fluorescence-minus-one controls were used to validate results. Samples were acquired on a Fortessa flow cytometer (BD Biosciences) and analyzed using FlowJo software v10 (FlowJo LLC, USA).
+ Open protocol
+ Expand
8

Activation of Human Naïve CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PBMCs and naïve CD4+ T cells were isolated from PBMCs using negative selection MACS microbeads (Miltenyi Biotec) as per manufacturer’s protocol. Cells were cultured in X-VIVO-15 medium (Lonza), in the presence of plate-bound antibody to CD3 (1 µg/ml, OKT3, eBiosience) and soluble antibody to CD28 (0.5 µg/ml, L293, BD Biosciences) for 5 days, with recombinant human IL-6 (20 ng/ml, Peprotech), IL-1β (10 ng/ml, Peprotech) , Tumor necrosis factor α (TNF-α, 10ng/ml, R&D), and L-Glutamine (Gln) as indicated. On day 5, the cells were stimulated with 20 ng/mL PMA and 1 µM ionomycin for 5 hours. Brefeldin A (10 µg/mL) was added after 1 hour. Cells were stained with LIVE/DEAD Blue (Life Technologies), then fixed and permeabilized with Cytofix/Cytoperm (BD Biosciences) as per manufacturer’s protocol, and stained with antibodies against CD3 (UCHT1 or SP34-2, BD Biosciences), CD4 (RPA-T4, BD Biosciences), CD8 (SK1, BD Biosciences), IFNγ (B27, BD Biosciences), IL-4 (8D4–8, BD Biosciences), and CD45RO (UCHL1, Beckman Coulter) antibodies.
+ Open protocol
+ Expand
9

Comprehensive Immune Profiling of CT26 Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
CT26 tumors were digested using a gentleMACS dissociator and a murine tumor dissociation kit (Miltenyi Biotec). Absolute viable cell counts were determined by propidium iodide staining and analysed on the MACSQuant analyzer. Cells from CT26 tumors and splenocytes were stained with fixable LIVE/DEAD blue (Life Technologies) and incubated with anti-mouse CD16/CD32 (eBioscience) prior to addition of anti-mouse: CD8-Pe-Cy7 (clone 53–6.7); CD3-eFluor 450 (clone 17A2); CD11c-PE (clone N418); CD86-FITC (clone GL1); PDCA1-APC (clone 129c) (eBioscience); PD-L1-BV421 (clone 10F.9G2); I-A/I-E (MHCII) (clone M5/114.15.2); B220-BV605 (clone RA3-6B2) (Biolegend); CD45-BV785 (clone 30F11); CD4-BUV395 (clone GK1.5); CD11b-BUV395 (clone M1/70); Ly6G-APC-Cy7 (clone 1A8); Ly6C-PerCP-Cy5.5 (clone AL-21) (BD Biosciences). For intracellular staining, cells were permeabilized using Foxp3 / Transcription Factor Staining Buffer Set (eBioscience) and incubated with anti-mouse Foxp3-PE (clone FJK-16S) and Ki67-eFluor 660 (clone SolA15) (eBioscience). Stained cells were fixed in 3.7% formaldehyde and analyzed using a BD LSRFortessa (BD Bioscience). Data analysis was performed using FlowJo (FlowJo LLC). 8 mice per treatment group were included in all flow cytometry analyses.
+ Open protocol
+ Expand
10

Activation and Phenotyping of T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Patients’ and healthy control (HC) PBMCs were purified by Ficoll density gradient centrifugation, washed with RPMI 1640 plus penicillin, streptomycin, and L-glutamine along with 10% FBS (R10) and filtered through a 40 µM strainer. Cells were resuspended to a concentration of 1 × 106 cells/mL and aliquoted (1 mL/well) into 48-well plates. PMA (final concentration 20 ng/mL), ionomycin (1 µM) and brefeldin A (5 µg/mL, Sigma-Aldrich) were added prior to incubation at 37°C for 5–6 hours. After incubation, cells were washed with FACS buffer and stained with LIVE/DEAD Blue (Life Technologies). Intracellular staining was performed using BD CytoFix/CytoPerm (BD Biosciences) reagents according to the manufacturer’s instructions using the following antibodies: CD3 (SK7, BD Biosciences), CD4 (RPA-T4, BD Biosciences), CD8 (SK1, BD Biosciences), CD45RO (UCHL1, Beckman Coulter), CXCR5 (RF8B2, BD Biosciences), CD25 (M-A251, BD Biosciences), IL-2 (MQ1–17H12, BioLegend), IL-4 (8D4–8, BD Biosciences), IL-5 (JES1–39D10, BD Biosciences), IL-13 (JES10-5A2, BD Biosciences), IFNγ (B27, BD Biosciences), IL-17A (eBio64DEC17, eBioscience). Cells were gated on viable CD3+ CD4+ CD45RO+ cells. Ex-vivo Treg staining was performed using anti-CD3 (UCHT1), CD4 (OKT4), CD25 (M-A251),, CD45RO (UCHL1), CD127 (HIL-7R–M21),, GATA3 (L50–823) and FOXP3 (236A/E7) antibodies as described 33 (link).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!